Chris Richardson, CEO of SafeHeal, will be presenting an overview of the benefits of Colovac to strategic partners....
SafeHeal® Receives European Marketing Approval Under MDR for Colovac® Anastomosis Protection Technology
SafeHeal announced that it has been granted European Union marketing approval for its Colovac device under the new Medical Device Regulation (EU MDR 2...
SafeHeal® Closes Oversubscribed €35 Million Series C Equity Financing
Breakthrough device promises significantly improved patient recovery after colorectal surgery....